3 years ago

One-pot biosynthesis of idoxuridine using nanostabilized lactic acid bacteria

One-pot biosynthesis of idoxuridine using nanostabilized lactic acid bacteria
An efficient bioprocess using immobilized lactic acid bacteria to obtain 5-iodouracil-2′-deoxyriboside, known as idoxuridine, is reported. This nucleoside analogue is an antiviral agent used in the treatment of viral infections in the absence of efficient vaccines. Idoxuridine conversion was close to 90% in different nonconventional media. A bionanocomposite (alginate-nanoclay) was employed as matrix to stabilize Lactobacillus animalis ATCC 35046 with improved stability in the presence of organic cosolvents. In this study, an eco-compatible and alternative bioprocess to obtain idoxuridine was developed for the first time. The scale-up biosynthesis of idoxuridine afforded a product yield close to 0.4gr/L in the presence of 20% of DMSO.

Publisher URL: www.sciencedirect.com/science

DOI: S1359511317309509

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.